WO2001036010A1 - Pansement absorbant pour blessures et procede de fabrication correspondant - Google Patents
Pansement absorbant pour blessures et procede de fabrication correspondant Download PDFInfo
- Publication number
- WO2001036010A1 WO2001036010A1 PCT/RU2000/000445 RU0000445W WO0136010A1 WO 2001036010 A1 WO2001036010 A1 WO 2001036010A1 RU 0000445 W RU0000445 W RU 0000445W WO 0136010 A1 WO0136010 A1 WO 0136010A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- πρi
- polysiloxane
- product
- wound
- nagρeve
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 4
- 230000002745 absorbent Effects 0.000 title abstract 5
- 239000002250 absorbent Substances 0.000 title abstract 5
- -1 polysiloxane Polymers 0.000 claims abstract description 9
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 9
- 238000001816 cooling Methods 0.000 claims abstract description 4
- 238000010438 heat treatment Methods 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims description 4
- 230000005611 electricity Effects 0.000 claims description 2
- 229920000548 poly(silane) polymer Polymers 0.000 claims description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 2
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 239000003575 carbonaceous material Substances 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 239000004744 fabric Substances 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 2
- 230000004913 activation Effects 0.000 abstract description 2
- 229910052799 carbon Inorganic materials 0.000 abstract description 2
- 230000035876 healing Effects 0.000 abstract description 2
- 230000002980 postoperative effect Effects 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 abstract 4
- 238000003763 carbonization Methods 0.000 abstract 2
- 229920000297 Rayon Polymers 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000004816 latex Substances 0.000 abstract 1
- 229920000126 latex Polymers 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 206010016717 Fistula Diseases 0.000 description 4
- 230000003890 fistula Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical class O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920000049 Carbon (fiber) Polymers 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F9/00—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
- D01F9/08—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments of inorganic material
- D01F9/12—Carbon filaments; Apparatus specially adapted for the manufacture thereof
- D01F9/14—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments
- D01F9/16—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments from products of vegetable origin or derivatives thereof, e.g. from cellulose acetate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
- A61F13/00991—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder
- A61F13/00995—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder for mechanical treatments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
Definitions
- the invention is available in medicine and may be used in the treatment of vomiting, sluggish, complicated complications of the stomach, fistula and burning, in 10 cases
- a multifaceted medical napkin which in turn has one of the layers - a layer
- a multi-layered wiring is known, containing several layers, one of which is
- High vascularity reduces the effectiveness of treatment, as it is associated with the risk of an increase in the severity of heart disease and is associated with an increase in the severity of the disease. After 0 time of a separate contact, the equilibrium state is established; This highly undesirable process can cause infection or other phenomena, which is 5 times faster, the higher the retention rate of the treatment, this is reduced.
- the dryness of the invention is an increase in the effectiveness of the treatment of infected infections, compared with a reduction of 5%.
- the consumer uses an organic product, selected from the group, which is part of acellum, teluela, 5.
- the russia bond has a low real estate (up to 1%), i.e. Processing 5 improves the ability to reduce the salary, as well as the resulting small-sized business connections are eliminated. Otherwise, maintaining the trading process in the company will increase the risk of material (only 0) ⁇ anevaya ⁇ vyaz ⁇ a ⁇ bladae ⁇ yavn ⁇ vy ⁇ azhennym gem ⁇ s ⁇ a ⁇ iches ⁇ im deys ⁇ viem, a ⁇ ivn ⁇ s ⁇ bi ⁇ ue ⁇ mi ⁇ bnye ⁇ ela, ⁇ imiches ⁇ ie vesches ⁇ va, ⁇ imenenie i ⁇ ⁇ e ⁇ mend ⁇ van ⁇ ⁇ i treatment ⁇ zh ⁇ g ⁇ vy ⁇ ⁇ an, ⁇ iches ⁇ i ⁇ ulcers, fistulas and 5 gn ⁇ yny ⁇ ⁇ an where ⁇ e ⁇ bladayu ⁇ ⁇ du ⁇ ivnye ⁇ tsessy,
- the accessory of the unit Due to its high hygroscopicity, the accessory of the unit is separated from the plant, it allows the absorption of toxic substances into the environment and the treatment system. 5
- the harness is set on a wound and is worn for 2-12 hours, depending on how many are separated. The cost of the dressing is unlimited, either for a complete cleansing of the cut and subsequent Explosion or imposing of secondary seams, or for full remodeling 0.
- Occupation is shared by the HKS 12088-77.
- the specific conversion of the compounds is determined by the low-temperature adsorption of nitrogen from the Brunauer, Emmet, and Zeller (BE) method. 5 Proposal for sharing the formula:
- the elementary carbon method of 5 materials with a size of 80x40 mm is placed in the crate and at a temperature of (110 + 5) ° C, it dries for 3 hours.
- a bus with a dried elementary weight is weighed at an analytical weight with an accuracy of up to 10 ⁇ 4 g.
- the elementary method is taken out of the box with the tweezers and fully loaded into a glass with a distilled water and temperature (20 + 2) ° ⁇ for 1 minute.
- the sample is placed on a flat, inaccessible surface.
- the measuring unit supplies two copper electrodes long up to 100 mm, located in parallel with a distance of 100 mm from a friend at a distance of 100 mm from a distance of 100 mm from a distance of 100 mm.
- the measuring compartment supplies a volume of about 5 kg, which creates a pressure of elec- trodes on a sample of 10 kPa ( ⁇ 20214-74).
- Measuring unit is connected to measuring unit ⁇ 4833 (class 5 of accuracy -0.1). Measurement of basic products (electrical equipment is provided on basis of basic items) and waste. Measurement is taken in a few places of the sample and the average result is recorded in the meter.
- EXAMPLE 1 The backbone - the tissue was used for the treatment of the rhizome, the use of the tissue did not cause natural phenomena and was painful.
- EXAMPLE 2 The backbone connection was used in the treatment of general pane of automatic genesis. Four of the four patients had extensive scalped burrs of flesh. In others, there is a defect in soft tissues and an outgrowth. The use of them was impaired by all the sick. The wipes indicate a pronounced hemostatic effect, there was no discharge, 5 of the more painful use of the wipes did not result in a free outcome.
- the rhizome sorbent is used in the treatment of muscular, sluggish, complicated, postoperative fistula and fistula. 5
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Manufacturing & Machinery (AREA)
- Inorganic Chemistry (AREA)
- Textile Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
L'invention porte sur un procédé de fabrication d'un bandage absorbant pour blessures et un bandage absorbant pour blessures qui est destiné au traitement des blessures postopératoires purulentes à cicatrisation lente; grâce à leurs bonnes propriétés hygroscopiques, ces bandages empêchent l'absorption des substances toxiques dans le sang et contribuent à réduire la durée de guérison. Selon l'invention, on obtient le bandage à base d'une matière carbonée tissée activée par l'imprégnation d'un tissu de base en viscose avec un polysiloxane, suivie de séchage, de carbonisation dans un environnement inerte accompagnée d'un réchauffage jusqu'à une température entre 180° et 600 °C et d'une activation par la vapeur d'eau avec un réchauffage à 930°, avec refroidissement subséquent. Avant la carbonisation, le tissu est soumis à une relaxation, accompagnée d'un réchauffage à 150° et d'une déformation allant jusqu'à -10 %. La matière carbonée ainsi obtenue est réduite en poudre, imprégnée de latex, séchée et découpée le long des lignes de séparation de manière à obtenir des bandages absorbants. Le bandage ainsi obtenu a une surface spécifique entre 600 et 2500 m2/g, une résistance électrique entre 3,5 et 10,5 Ohm, une capacité d'absorption de l'humidité entre 300 et 500 % et une perméabilité à l'air entre 100 et 150 dm3/m/2/s.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU14240/01A AU1424001A (en) | 1999-11-15 | 2000-11-02 | Method for the production of an absorbent bandage for a wound and absorbent bandage for a wound |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU99124239 | 1999-11-15 | ||
| RU99124239/14A RU2173175C2 (ru) | 1999-11-15 | Раневая сорбирующая повязка |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2001036010A1 true WO2001036010A1 (fr) | 2001-05-25 |
Family
ID=20227086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/RU2000/000445 WO2001036010A1 (fr) | 1999-11-15 | 2000-11-02 | Pansement absorbant pour blessures et procede de fabrication correspondant |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU1424001A (fr) |
| WO (1) | WO2001036010A1 (fr) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003039417A3 (fr) * | 2001-11-06 | 2003-10-02 | Gorix Ltd | Pansement chauffant |
| US7238196B2 (en) | 2003-10-31 | 2007-07-03 | Avery Dennison Corporation | Skin-contacting heatable dressing |
| WO2010094426A1 (fr) | 2009-02-19 | 2010-08-26 | Roche Diagnostics Gmbh | Procédé de fabrication d'un chargeur pour analyses |
| WO2012140027A1 (fr) | 2011-04-12 | 2012-10-18 | Roche Diagnostics Gmbh | Outil d'analyse |
| US9726612B2 (en) | 2011-04-12 | 2017-08-08 | Roche Diabetes Care, Inc. | Analytical aid |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0311364A2 (fr) * | 1987-10-06 | 1989-04-12 | JOHNSON & JOHNSON | Pansement au charbon actif |
| RU2045472C1 (ru) * | 1992-09-04 | 1995-10-10 | Казаков Марк Евгеньевич | Способ получения углеродного волокнистого материала |
| RU2049168C1 (ru) * | 1992-08-31 | 1995-11-27 | Электростальское научно-производственное объединение "Неорганика" | Способ получения углеродного волокнистого адсорбента |
-
2000
- 2000-11-02 WO PCT/RU2000/000445 patent/WO2001036010A1/fr active Application Filing
- 2000-11-02 AU AU14240/01A patent/AU1424001A/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0311364A2 (fr) * | 1987-10-06 | 1989-04-12 | JOHNSON & JOHNSON | Pansement au charbon actif |
| RU2049168C1 (ru) * | 1992-08-31 | 1995-11-27 | Электростальское научно-производственное объединение "Неорганика" | Способ получения углеродного волокнистого адсорбента |
| RU2045472C1 (ru) * | 1992-09-04 | 1995-10-10 | Казаков Марк Евгеньевич | Способ получения углеродного волокнистого материала |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003039417A3 (fr) * | 2001-11-06 | 2003-10-02 | Gorix Ltd | Pansement chauffant |
| GB2396823A (en) * | 2001-11-06 | 2004-07-07 | Gorix Ltd | Heated wound dressing |
| GB2396823B (en) * | 2001-11-06 | 2005-06-01 | Gorix Ltd | Heated wound dressing |
| US7238196B2 (en) | 2003-10-31 | 2007-07-03 | Avery Dennison Corporation | Skin-contacting heatable dressing |
| WO2010094426A1 (fr) | 2009-02-19 | 2010-08-26 | Roche Diagnostics Gmbh | Procédé de fabrication d'un chargeur pour analyses |
| EP2226008A1 (fr) | 2009-02-19 | 2010-09-08 | Roche Diagnostics GmbH | Procédé de fabrication d'un chargeur analytique |
| EP2286725A1 (fr) | 2009-02-19 | 2011-02-23 | Roche Diagnostics GmbH | Procédé de fabrication d'un chargeur analytique |
| WO2012140027A1 (fr) | 2011-04-12 | 2012-10-18 | Roche Diagnostics Gmbh | Outil d'analyse |
| US9097679B2 (en) | 2011-04-12 | 2015-08-04 | Roche Diabetes Care, Inc. | Analytical aid |
| EP2977004A1 (fr) | 2011-04-12 | 2016-01-27 | Roche Diagniostics GmbH | Moyen d'aide analytique |
| US9726612B2 (en) | 2011-04-12 | 2017-08-08 | Roche Diabetes Care, Inc. | Analytical aid |
Also Published As
| Publication number | Publication date |
|---|---|
| AU1424001A (en) | 2001-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2695622B1 (fr) | Pansement pour plaies à base de chitosane et son procédé de fabrication | |
| RU2391116C1 (ru) | Способы изготовления противомикробных влажных раневых повязок со связанным серебром и влажные раневые повязки, изготовленные этими способами | |
| Saha et al. | Polymeric biomaterial based hydrogels for biomedical applications | |
| EP2863961B1 (fr) | Dispositifs hémostatiques | |
| JP2020000857A (ja) | 抗菌創傷被覆材 | |
| CA2490847C (fr) | Pansement antimicrobien contenant de l'argent a liberation continue | |
| Li et al. | Antibacterial strategies for wound dressing: preventing infection and stimulating healing | |
| JP2008532662A (ja) | 抗菌創傷包帯の作製方法およびその使用 | |
| US20110071227A1 (en) | Rapidly wetting material containing hydrocolloid, method for the manufacture thereof and use thereof | |
| KR20090027838A (ko) | 수분 감응성 피브리드즈 조성물 및 그 제조방법 | |
| US20070065503A1 (en) | Active substance-doped absorbing polymer particles, composition comprising polycondensate matrix and absorbant polymer for release of a wound treatment substance | |
| JP4808402B2 (ja) | 陰イオン多糖と銀の複合体を含む創傷包帯材料 | |
| WO2001036010A1 (fr) | Pansement absorbant pour blessures et procede de fabrication correspondant | |
| CN106947095A (zh) | 一种用于伤口愈合抑菌型水凝胶的制备方法 | |
| WO2014072721A1 (fr) | Dispositif de soins de plaie | |
| US9907879B2 (en) | Haemostatic composition comprising crystalline polyphosphate | |
| WO2020213012A1 (fr) | Nanofibres auto-assemblées en tant qu'agent hémostatique | |
| JP3599741B2 (ja) | アルギン酸塩繊維、その製法及び用途 | |
| CN101141985A (zh) | 抗菌医用敷料的制造方法及其用途 | |
| ES2443151T3 (es) | Fibras de carboxietilcelulosa, su uso en apósitos y artículos de higiene y procedimiento para su preparación | |
| Bell et al. | Choosing an appropriate dressing for chronic wounds | |
| RU2163147C1 (ru) | Способ изготовления кровоостанавливающего пластыря | |
| CN100339522C (zh) | 一种靶向性吸附型活性炭纤维材料及其制备方法和栓型产品 | |
| RU2173175C2 (ru) | Раневая сорбирующая повязка | |
| JPH08322874A (ja) | 生体適合性粘着パッド |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase |